Edward M. MD Kaye, a director at $STOK, sold 11,930 shares of the company on 08-18-2026 for an estimated $381,845. We received data on the trade from a recent SEC filing. This was a sale of approximately 8.7% of their shares of this class of stock. Following this trade, they now own 125,194 shares of this class of $STOK stock.
$STOK Insider Trading Activity
$STOK insiders have traded $STOK stock on the open market 39 times in the past 6 months. Of those trades, 0 have been purchases and 39 have been sales.
Here’s a breakdown of recent trading of $STOK stock by insiders over the last 6 months:
- ADRIAN R. KRAINER has made 0 purchases and 2 sales selling 40,472 shares for an estimated $1,607,678.
- BARRY TICHO (CHIEF MEDICAL OFFICER) has made 0 purchases and 13 sales selling 34,591 shares for an estimated $1,089,756.
- JONATHAN ALLAN (GENERAL COUNSEL & CORP SEC) has made 0 purchases and 10 sales selling 22,506 shares for an estimated $734,215.
- EDWARD M. MD KAYE has made 0 purchases and 2 sales selling 12,567 shares for an estimated $402,528.
- ARTHUR TZIANABOS (Interim Executive Chair) sold 4,355 shares for an estimated $174,214
- THOMAS LEGGETT (Chief Financial Officer) has made 0 purchases and 5 sales selling 4,578 shares for an estimated $147,144.
- JASON HOITT (Chief Patient Officer) has made 0 purchases and 5 sales selling 3,712 shares for an estimated $119,310.
- ARTHUR A LEVIN sold 605 shares for an estimated $22,264
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$STOK Hedge Fund Activity
We have seen 106 institutional investors add shares of $STOK stock to their portfolio, and 102 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. added 2,415,139 shares (+inf%) to their portfolio in Q2 2026, for an estimated $79,023,348
- POINT72 ASSET MANAGEMENT, L.P. removed 1,222,213 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $39,795,255
- PRICE T ROWE ASSOCIATES INC /MD/ added 727,568 shares (+37.6%) to their portfolio in Q2 2026, for an estimated $23,806,024
- LYNX1 CAPITAL MANAGEMENT LP removed 641,001 shares (-11.9%) from their portfolio in Q1 2026, for an estimated $20,870,992
- ECOR1 CAPITAL, LLC added 635,000 shares (+635.0%) to their portfolio in Q2 2026, for an estimated $20,777,200
- STATE STREET CORP added 575,728 shares (+25.3%) to their portfolio in Q2 2026, for an estimated $18,837,820
- BLACKROCK, INC. added 491,643 shares (+9.1%) to their portfolio in Q2 2026, for an estimated $16,086,558
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$STOK Analyst Ratings
Wall Street analysts have issued reports on $STOK in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Canaccord Genuity issued a "Buy" rating on 03/20/2026
To track analyst ratings and price targets for $STOK, check out Quiver Quantitative's $STOK forecast page.
$STOK Price Targets
Multiple analysts have issued price targets for $STOK recently. We have seen 6 analysts offer price targets for $STOK in the last 6 months, with a median target of $39.5.
Here are some recent targets:
- Thomas Shrader from BTIG set a target price of $39.0 on 05/11/2026
- Sumant Kulkarni from Canaccord Genuity set a target price of $60.0 on 03/20/2026
- Laura Chico from Wedbush set a target price of $38.0 on 03/18/2026
- Keay Nakae from Chardan Capital set a target price of $35.0 on 03/18/2026
- Joseph Stringer from Needham set a target price of $40.0 on 03/17/2026
- Rudy Li from Wolfe Research set a target price of $40.0 on 02/24/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
